Kim Cheung-Kue, Oh Sunju, Kim Sook-Ja, Leem Sun-Hee, Heo Jeonghoon, Chung So-Hak
Department of Orthopedic Surgery, College of Medicine, Kosin University, Gospel Hospital, 262 Gamcheon-ro, Seo-gu, Busan, 49267, South Korea.
Department of Orthopedic Surgery, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Genes Genomics. 2018 Apr;40(4):381-388. doi: 10.1007/s13258-017-0639-z. Epub 2017 Dec 1.
Osteosarcoma is the most common type of malignant bone tumors. Insulin Growth Factor 1 receptor (IGFR1) has been known as a prognostic factor for metastasis of osteosarcoma. ABC subfamily G member2 (ABCG2) is related to resistance to anti-cancer drug, and CD44 has a role in tumor growth and metastasis. The purpose of this study is to investigate the relationship among expression patterns of IGF1R, ABCG2, and CD44 in osteosarcoma. The expression levels of IGF1R, ABCG2, and CD44 proteins were determined in tissue arrays containing osteosarcoma tissues from 59 osteosarcoma patients. The expression pattern of IGF1R was highly correlated with the expression pattern of ABCG2 (r = 0.88) in overall osteosarcoma patients. According to pathological types, the expression pattern of IGF1R showed the higher correlation with ABGC2 (r = 0.90) and CD44 (r = 0.61) in osteoblatic type than in chondroblastic type. According to gender with pathologic type, the correlation between the expression patterns of IGF1R and CD44 was higher in male with osteoblatic type than in female with osteoblatic type. Among different age groups, the 1-10 years age group showed higher correlation in IGF1R versus CD44 (r = 0.90) and ABCG2 versus CD44 (0.80) than in other age groups. These results showed that the expression of IGF1R appears to be highly correlated with the expression of ABCG2 in osteosarcoma and with the expression of CD44 in osteosarcoma patients under age of 10, which suggests that ABCG2 and CD44 can be used as prognostic factors with IGF1R for specific prognosis and efficient treatment of osteosarcoma.
骨肉瘤是最常见的恶性骨肿瘤类型。胰岛素生长因子1受体(IGFR1)一直被认为是骨肉瘤转移的一个预后因素。ABC亚家族G成员2(ABCG2)与抗癌药物耐药性有关,而CD44在肿瘤生长和转移中起作用。本研究的目的是探讨骨肉瘤中IGF1R、ABCG2和CD44表达模式之间的关系。在包含59例骨肉瘤患者骨肉瘤组织的组织芯片中测定了IGF1R、ABCG2和CD44蛋白的表达水平。在总体骨肉瘤患者中,IGF1R的表达模式与ABCG2的表达模式高度相关(r = 0.88)。根据病理类型,成骨型骨肉瘤中IGF1R的表达模式与ABGC2(r = 0.90)和CD44(r = 0.61)的相关性高于软骨母细胞型。根据病理类型的性别分析,成骨型男性中IGF1R和CD44表达模式之间的相关性高于成骨型女性。在不同年龄组中,1 - 10岁年龄组中IGF1R与CD44(r = 0.90)以及ABCG2与CD44(0.80)的相关性高于其他年龄组。这些结果表明,在骨肉瘤中IGF1R的表达似乎与ABCG2的表达高度相关,在10岁以下的骨肉瘤患者中与CD44的表达高度相关,这表明ABCG2和CD44可作为与IGF1R一起用于骨肉瘤特定预后和有效治疗的预后因素。